Cargando…
Dexmedetomidine reduces sevoflurane EC(50) for supraglottic airway device insertion in spontaneously breathing morbidly obese patients
Purpose: This study aimed to assess the effect of intravenous dexmedetomidine (DEX) on sevoflurane EC(50) for supraglottic airway device (SAD) insertion in spontaneously breathing morbidly obese patients. Patients and methods: Thirty-eight morbidly obese patients with a body mass index 40–57 kg/m(2)...
Autores principales: | Wan, Lei, Shao, Liu-Jia-Zi, Liu, Yang, Wang, Hai-Xia, Xue, Fu-Shan, Tian, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504637/ https://www.ncbi.nlm.nih.gov/pubmed/31118650 http://dx.doi.org/10.2147/TCRM.S199440 |
Ejemplares similares
-
The optimum sevoflurane concentration for supraglottic airway device Blockbuster™ insertion with spontaneous breathing in obese patients: a prospective observational study
por: Wang, Haixia, et al.
Publicado: (2017) -
A feasibility study of jaw thrust as an indicator assessing adequate depth of anesthesia for insertion of supraglottic airway device in morbidly obese patients
por: Wan, Lei, et al.
Publicado: (2019) -
EC(50) of sevoflurane for classic laryngeal mask airway insertion in children at different time points: A randomized blind trial
por: Sethi, Sameer, et al.
Publicado: (2020) -
Optimum end-tidal concentration of sevoflurane to facilitate supraglottic airway device insertion with propofol at induction allowing spontaneous respiration in obese patients: A prospective observational study
por: Wang, Hai-Xia, et al.
Publicado: (2017) -
Success Rate of Airway Devices Insertion: Laryngeal Mask Airway Versus Supraglottic Gel Device
por: Pournajafian, Alireza, et al.
Publicado: (2015)